Back to Search
STEPHEN HAUSER, M.D.
M.D.
Internal Medicine Physician
NPI: 1700996931IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G75715(CA)
Neurology Physician
Psychiatry & Neurology — Neurology
Code: 2084N0400X
G75715(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1975
Research & Publications (20)
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
PMID 18272891·N Engl J Med·2008
3-trial
Saving the clinician-scientist: report of the ANA long range planning committee.
PMID 16983684·Ann Neurol·2006
8-other
The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
PMID 17015227·Neuron·2006
6-review
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.
PMID 10802800·Neurology·2000
8-other
PubMed on Tap: discovering design principles for online information delivery to handheld computers.
PMID 15361051·Stud Health Technol Inform·2004
8-other
Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.
PMID 10748014·J Biol Chem·2000
7-preclinical
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
PMID 19525953·Nat Genet·2009
8-other
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
PMID 19286671·Hum Mol Genet·2009
8-other
Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis.
PMID 19626040·Genes Immun·2009
8-other
Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.
PMID 19451531·Neurology·2009
8-other
Association of tinnitus and electromagnetic hypersensitivity: hints for a shared pathophysiology?
PMID 19325894·PLoS One·2009
8-other
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.
PMID 19293837·Eur J Hum Genet·2009
8-other
Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide.
PMID 19675744·Ger Med Sci·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 350 PARNASSUS AVE # 908
SAN FRANCISCO, CA 94143 - Phone
- (415) 476-9211
Quick Facts
- NPI
- 1700996931
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile